PR PolyResearch

Join Free

NYSE

AstraZeneca PLC Ordinary Shares (AZN)

♥ 390 Thanks from members

AstraZeneca PLC (AZN) exhibits a divided market sentiment, balancing robust oncology growth and a strong pipeline targeting $80B by 2030 against patent cliff concerns, China regulatory risks, and valuation pressures.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other NYSE Tickers

Rayonier Inc. REIT (RYN)

Blackstone Inc. (BX)

Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) American Depositary Shares (EDN)

Miami International Holdings, Inc. (MIAX)

Bob's Discount Furniture, Inc. (BOBS)

USANA Health Sciences, Inc. (USNA)